Cargando…
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
PURPOSE: Clinicopathologic features and biochemical recurrence are sensitive, but not specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a genomic expression signature detected in the primary tumor represents true biological potential of aggressive disease and...
Autores principales: | Erho, Nicholas, Crisan, Anamaria, Vergara, Ismael A., Mitra, Anirban P., Ghadessi, Mercedeh, Buerki, Christine, Bergstralh, Eric J., Kollmeyer, Thomas, Fink, Stephanie, Haddad, Zaid, Zimmermann, Benedikt, Sierocinski, Thomas, Ballman, Karla V., Triche, Timothy J., Black, Peter C., Karnes, R. Jeffrey, Klee, George, Davicioni, Elai, Jenkins, Robert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691249/ https://www.ncbi.nlm.nih.gov/pubmed/23826159 http://dx.doi.org/10.1371/journal.pone.0066855 |
Ejemplares similares
-
Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
por: Vergara, Ismael A., et al.
Publicado: (2012) -
Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer
por: Mitra, Anirban P., et al.
Publicado: (2014) -
Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012) -
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
por: Badani, Ketan, et al.
Publicado: (2013) -
Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
por: Lee, Hak J, et al.
Publicado: (2016)